These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37003027)

  • 21. Effectiveness of a live oral human rotavirus vaccine after programmatic introduction in Bangladesh: A cluster-randomized trial.
    Zaman K; Sack DA; Neuzil KM; Yunus M; Moulton LH; Sugimoto JD; Fleming JA; Hossain I; Arifeen SE; Azim T; Rahman M; Lewis KDC; Feller AJ; Qadri F; Halloran ME; Cravioto A; Victor JC
    PLoS Med; 2017 Apr; 14(4):e1002282. PubMed ID: 28419095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The economic burden of rotavirus hospitalization among children < 5 years of age in selected hospitals in Bangladesh.
    Ahmed S; Dorin F; Satter SM; Sarker AR; Sultana M; Gastanaduy PA; Parashar U; Tate JE; Heffelfinger JD; Gurley ES; Khan JAM
    Vaccine; 2021 Nov; 39(48):7082-7090. PubMed ID: 34756769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized, open-labelled, non-inferiority phase 4 clinical trial to evaluate the immunogenicity and safety of the live, attenuated, oral rotavirus vaccine, ROTAVAC® in comparison with a licensed rotavirus vaccine in healthy infants.
    Ella R; Babji S; Ciarlet M; Blackwelder WC; Vadrevu KM
    Vaccine; 2019 Jul; 37(31):4407-4413. PubMed ID: 31178377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health impact and cost-effectiveness of a domestically-produced rotavirus vaccine in India: A model based analysis.
    Rose J; Homa L; Meropol SB; Debanne SM; Bielefeld R; Hoyen C; Singer ME
    PLoS One; 2017; 12(11):e0187446. PubMed ID: 29099848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of rotavirus vaccination in Ghana: Examining impacts from 2012 to 2031.
    Nonvignon J; Atherly D; Pecenka C; Aikins M; Gazley L; Groman D; Narh CT; Armah G
    Vaccine; 2018 Nov; 36(47):7215-7221. PubMed ID: 29223486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of childhood rotavirus vaccination in Taiwan.
    Wu CL; Yang YC; Huang LM; Chen KT
    Vaccine; 2009 Mar; 27(10):1492-9. PubMed ID: 19186200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of rotavirus vaccination in Kenya and Uganda.
    Sigei C; Odaga J; Mvundura M; Madrid Y; Clark AD; ;
    Vaccine; 2015 May; 33 Suppl 1():A109-18. PubMed ID: 25919149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness of rotavirus vaccination in Albania.
    Ahmeti A; Preza I; Simaku A; Nelaj E; Clark AD; Felix Garcia AG; Lara C; Hoestlandt C; Blau J; Bino S
    Vaccine; 2015 May; 33 Suppl 1():A201-8. PubMed ID: 25919162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of geographic and economic heterogeneity on the burden of rotavirus diarrhea and the impact and cost-effectiveness of vaccination in Pakistan.
    Rheingans R; Anderson JD; Bagamian KH; Laytner LA; Pecenka CJ; Gilani SSA; Ahmed M
    Vaccine; 2018 Dec; 36(51):7780-7789. PubMed ID: 30007826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimated impact and cost-effectiveness of rotavirus vaccination in Senegal: A country-led analysis.
    Diop A; Atherly D; Faye A; Lamine Sall F; Clark AD; Nadiel L; Yade B; Ndiaye M; Fafa Cissé M; Ba M
    Vaccine; 2015 May; 33 Suppl 1():A119-25. PubMed ID: 25919151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Budget impact and cost-utility analysis of universal infant rotavirus vaccination in Spain.
    Imaz I; Rubio B; Cornejo AM; González-Enríquez J
    Prev Med; 2014 Apr; 61():116-21. PubMed ID: 24360847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Economic evaluation of the national immunization program of rotavirus vaccination for children in Korea.
    Kang HY; Kim KH; Kim JH; Kim HM; Kim J; Kim MS; El Khoury AC; Kim DS
    Asia Pac J Public Health; 2013 Mar; 25(2):145-58. PubMed ID: 22234827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness of universal rotavirus vaccination in reducing rotavirus gastroenteritis in Ireland.
    Tilson L; Jit M; Schmitz S; Walsh C; Garvey P; McKeown P; Barry M
    Vaccine; 2011 Oct; 29(43):7463-73. PubMed ID: 21821085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing the introduction of universal rotavirus vaccination in the Netherlands.
    Zomer TP; van Duynhoven YT; Mangen MJ; van der Maas NA; Vennema H; Boot H; de Melker HE
    Vaccine; 2008 Jul; 26(29-30):3757-64. PubMed ID: 18514975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-benefit analysis of rotavirus vaccine included in the national immunization program in China.
    Chen S; Gao S; Li J; Li J; Duan ZJ
    Vaccine; 2023 Jan; 41(2):547-554. PubMed ID: 36503856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anticipating rotavirus vaccines: hospital-based surveillance for rotavirus diarrhea and estimates of disease burden in Bangladesh.
    Unicomb LE; Kilgore PE; Faruque SG; Hamadani JD; Fuchs GJ; Albert MJ; Glass RI
    Pediatr Infect Dis J; 1997 Oct; 16(10):947-51. PubMed ID: 9380469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hospital-based Surveillance for Rotavirus Gastroenteritis Among Young Children in Bangladesh: Defining the Potential Impact of a Rotavirus Vaccine Program.
    Satter SM; Gastanaduy PA; Islam K; Rahman M; Rahman M; Luby SP; Heffelfinger JD; Parashar UD; Gurley ES
    Pediatr Infect Dis J; 2017 Feb; 36(2):168-172. PubMed ID: 27798545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An economic analysis of rotavirus vaccination in Italy.
    Giammanco MD; Coniglio MA; Pignato S; Giammanco G
    Vaccine; 2009 Jun; 27(29):3904-11. PubMed ID: 19446934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness of childhood rotavirus vaccination in Germany.
    Aidelsburger P; Grabein K; Böhm K; Dietl M; Wasem J; Koch J; Ultsch B; Weidemann F; Wichmann O
    Vaccine; 2014 Apr; 32(17):1964-74. PubMed ID: 24561052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The cost-effectiveness of pentavalent rotavirus vaccination in England and Wales.
    Atkins KE; Shim E; Carroll S; Quilici S; Galvani AP
    Vaccine; 2012 Nov; 30(48):6766-76. PubMed ID: 23000223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.